期刊文献+

北京市某社区医院内科患者抗血小板治疗分析 被引量:3

Analysis of aspirin administration in patients with cardiovascular risk factors in a community hospital in Beijing
下载PDF
导出
摘要 目的调查北京某社区医院住院患者抗血小板药物应用现状及其影响因素,以了解北京基层医院心脑血管病患者一、二级防治现状。方法采用病例调查的方法,顺序选取在北京玉泉山地区某社区医院内科住院的790例具有服用阿司匹林的指征的患者中,对其存在的心血管病危险因素、是否使用阿司匹林及影响因素进行分析。结果 790例患者中,516人使用了阿司匹林占65.3%。阿司匹林的二级预防情况稍好于一级预防(P<0.05)。Logistic回归分析显示冠心病、脑卒中、担心发生或已经发生的不良反应是导致患者未规范使用阿司匹林的重要原因。结论目前我国基层医院阿司匹林的正确使用率仍然较低,需进一步加大宣传教育力度,提高医务人员对各种指南的认识程度及防病意识。 Objective To investigate the prophylactic use of aspirin in patients with cardiovascular risk factors in a community hospital in Beijing.Methods 790 hospitalized patients with indications for anti-platelet therapy were investigated consecutively on the influential factors.Results Only 516 of 790(63.5%)patients were administrated with aspirin.The aspirin administration for secondary prevention is better than that for primary prevention.Multiple-factor logistic regression analysis confirmed that coronary heart disease,stroke and adverse reaction were main risk factors related to aspirin administration.Conclusion The rate of aspirin administration is relatively low in our community hospital.Education should be strengthened for doctors and patients in community hospitals in China.
出处 《中国临床保健杂志》 CAS 2011年第2期151-153,共3页 Chinese Journal of Clinical Healthcare
关键词 血小板聚集抑制剂 阿司匹林 心血管疾病 横断面研究 Platelet aggregation inhibitors Aspirin Cordiovascular disease Cross-sectional studies
  • 相关文献

参考文献5

  • 1Wolf PA,D Agostino RB,Belanger AJ,et al.Probability of stroke:a risk profile from the framingham study[J].Stroke,1991,22(3):312-318.
  • 2Farrell B,Godwin J,Richards S,et al.The United Kingdom transient ischemic attack(UK-T1A)aspirin trial:final results[J].J Neurol Neurosurg Psychiatry,1991,54(12):1044-1054.
  • 3司全金,李小鹰.老年雄激素低下患者血液凝血和纤溶系统的变化[J].中华老年心脑血管病杂志,2005,7(3):157-159. 被引量:12
  • 4Wolff T,Miller T,Ko S.Aspirin for the primary prevention of cardiovascular events:an update of the evidence for the U.S.preventive services task force[J].Ann Intern Med,2009,150(6):405-410.
  • 5Marshall T,Rous A.Coronary heart disease prevention:insights from modeling incremental cost effectiveness[J].BMJ,2002,325(7370):197-756.

二级参考文献11

  • 1李江源,李小鹰,李明,张高魁,马芳玲,刘志明,张南雁,孟萍.健康成年男子性激素水平调查[J].中华老年心脑血管病杂志,2004,6(4):232-234. 被引量:22
  • 2Lerrer DJ, kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow up of the Framingham study[J]. Am Heart J,1986,111:383-390.
  • 3Phillips GB, Pinkemell BH, Jing TY. The association of hypotester-onemia with coronary thrombosis in men [J]. Arteriosclero Thromb,1996,16:1383-1387.
  • 4Vermeulen A, Verdonck L, Kaufman JM, et al. A critical evaluation of simple methods for the estimation of free testosterone in serum[J].J CAin Endocrinol Metab, 1999, 84:3666-3672.
  • 5Feldman CL, Stone PH. lntravascular hemodynamic factors responsible for progression of coronary atherosclerosis development of vulnerable plaque [J]. Curr Opin C.ardiol,2000,15:430-440.
  • 6Reiner AP, Siscovick DS, Rossendaal FR. Hemostatic risk factors and arterial thrombotic disease[J]. Thramb Haemost,2001,85:584-595.
  • 7Ferenchick GS, Hirokawa S, Mammen EF, et al. Anabolic-tmdngenic steroid abuse in weight lifters:evidence for activation of the hemostatic system[J]. Am J Hematol,1995,49:282-288.
  • 8Callum L, Mary C. Sex steroids and insulin resistance[J]. Clin Sci,2002,201 : 151-166.
  • 9Winkler UH. Effects of androgens on haemostasis[J].Maturitas,1996,24:147-155.
  • 10Shapiro J, Christiana J, Frishman WH.Testosterone and other anabolic steroids as cardiovascular drugs[J] .Am J Ther, 1999,6:167-174.

共引文献11

同被引文献61

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部